Articles published by Roivant Sciences![]()
Roivant Reports Financial Results for the First Quarter Ended June 30, 2024, and Provides Business Update
August 08, 2024
From Roivant Sciences
Via GlobeNewswire
Tickers
ROIV
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
December 20, 2023
From Roivant Sciences
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() From Roivant Sciences
Via GlobeNewswire
![]() ![]() ![]() ![]()
Roivant Announces Completion of Redemption of its Outstanding Warrants
September 11, 2023
From Roivant Sciences
Via GlobeNewswire
![]() ![]() ![]() ![]()
Roivant Announces Redemption of Outstanding Warrants
August 02, 2023
From Roivant Sciences
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Kelownadailycourier.ca
Phone number: (250) 763-4000
E-mail: csr@ok.bc.ca
Address: 550 Doyle Avenue
Kelowna, BC V1Y 7V1
© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.